| Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and … N Nasiri-Ansari, C Nikolopoulou, K Papoutsi, I Kyrou, CS Mantzoros, ... International journal of molecular sciences 22 (2), 818, 2021 | 208 | 2021 |
| Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms G Kyriakopoulos, V Mavroeidi, E Chatzellis, GA Kaltsas, KI Alexandraki Annals of translational medicine 6 (12), 2018 | 87 | 2018 |
| Total hip arthroplasty through an anterior approach: the pros and cons G Kyriakopoulos, L Poultsides, P Christofilopoulos EFORT open reviews 3 (11), 574-583, 2018 | 57 | 2018 |
| Management of neuroendocrine tumors of unknown primary K Alexandraki, A Angelousi, G Boutzios, G Kyriakopoulos, D Rontogianni, ... Reviews in Endocrine and Metabolic Disorders 18, 423-431, 2017 | 41 | 2017 |
| The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms A Angelousi, G Kyriakopoulos, N Nasiri-Ansari, M Karageorgou, E Kassi Annals of Translational Medicine 6 (12), 2018 | 26 | 2018 |
| Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin. KI Alexandraki, M Tsoli, G Kyriakopoulos, A Angelousi, G Nikolopoulos, ... Minerva Endocrinologica 44 (4), 378-386, 2019 | 17 | 2019 |
| Expression of clock-related genes in benign and malignant adrenal tumors A Angelousi, N Nasiri-Ansari, A Karapanagioti, G Kyriakopoulos, C Aggeli, ... Endocrine 68, 650-659, 2020 | 14 | 2020 |
| Changing biological behaviour of NETs during the evolution of the disease: progress on progression KI Alexandraki, A Spyroglou, S Kykalos, K Daskalakis, G Kyriakopoulos, ... Endocrine-Related Cancer 28 (5), R121-R140, 2021 | 13 | 2021 |
| Distinctive features of pancreatic neuroendocrine neoplasms exhibiting an increment in proliferative activity during the course of the disease KI Alexandraki, M Kaltsatou, G Kyriakopoulos, V Mavroeidi, ... Endocrine 72, 279-286, 2021 | 12 | 2021 |
| Optimizing fixation methods for stable and unstable intertrochanteric hip fractures treated with sliding hip screw or cephalomedullary nailing: A comparative biomechanical and … G Kyriakopoulos, A Panagopoulos, E Pasiou, SK Kourkoulis, ... Injury 53 (12), 4072-4085, 2022 | 11 | 2022 |
| The role of immunohistochemical markers for the diagnosis and prognosis of adrenocortical neoplasms A Angelousi, G Kyriakopoulos, F Athanasouli, A Dimitriadi, E Kassi, ... Journal of Personalized Medicine 11 (3), 208, 2021 | 11 | 2021 |
| A giant intrathoracic malignant schwannoma causing respiratory failure in a patient without von Recklinghausen’s disease E Angelopoulos, K Eleftheriou, G Kyriakopoulos, K Athanassiadi, ... Case reports in Medicine 2016 (1), 2541290, 2016 | 10 | 2016 |
| Postoperative complications after endoscope-assisted transsphenoidal surgery for pituitary adenomas: a case series, systematic review, and meta-analysis of the literature P Stefanidis, G Kyriakopoulos, F Athanasouli, C Mytareli, G Τzanis, ... Hormones 21 (3), 487-499, 2022 | 8 | 2022 |
| Cold snare polypectomy vs. hot snare polypectomy vs. argon plasma coagulation for small (5–9mm) left-sided colorectal polyps: a prospective randomized trial L Varytimiadis, N Viazis, P Gkolfakis, G Tribonias, G Tziatzios, ... European Journal of Gastroenterology & Hepatology 33 (1S), e909-e915, 2021 | 8 | 2021 |
| Adrenocortical cancer: A 20-year experience of a single referral center in prognosis and outcomes C Parianos, G Kyriakopoulos, ID Kostakis, N Nasiri-Ansari, C Aggeli, ... Hormone and Metabolic Research 53 (11), 709-716, 2021 | 7 | 2021 |
| Prognostic Factors for Invasiveness and Recurrence of Pituitary Adenomas: A Series of 94 Patients P Stefanidis, G Kyriakopoulos, AM Seretis, S Korfias, S Theocharis, ... Diagnostics 12 (10), 2413, 2022 | 4 | 2022 |
| Role of receptor profiling for personalized therapy in a patient with a growth hormone-secreting macroadenoma resistant to first-generation somatostatin analogues KI Alexandraki, E Papadimitriou, V Mavroeidi, G Kyriakopoulos, A Xydakis, ... Journal of Personalized Medicine 9 (4), 48, 2019 | 4 | 2019 |
| Immunotherapeutics at the spearhead: current status in targeting neuroendocrine neoplasms A Koumarianou, GA Kaltsas, E Chatzellis, G Kyriakopoulos, D Kolomodi, ... Endocrine 73, 232-239, 2021 | 3 | 2021 |
| Complete and sustained remission of hypercortisolism with pasireotide treatment of an adrenocorticotropic hormone (ACTH)-secreting thoracic neuroendocrine tumor: an n-of-1 trial ZA Efstathiadou, E Divaris, A Michou, G Kyriakopoulos, MD Kita Endocrine Journal 70 (2), 229-232, 2023 | 2 | 2023 |
| When rare diseases crisscross within the same patient: von Hippel-Lindau and type 1 gastric neuroendocrine tumor KI Alexandraki, A Spyroglou, P Xekouki, KI Bramis, G Kyriakopoulos, ... Hormones, 1-6, 2024 | 1 | 2024 |
